Paxlovid, Pfizer’s highly effective antiviral pill, was in short supply a few months ago when it was first authorized for use, but that’s no longer the case.

The federal government is currently making 175,000 doses of Paxlovid available each week, according to HHS data. These doses are allocated to states, territories, the federal test-to-treat program and long term care facilities.

But states are ordering only around two-thirds of what’s available to them, and are using around half of what they order, a senior Biden administration official told Axios.

In total — including the federal test-to-treat program and what states have ordered — around 47,000 doses were administered the week of April 17.